VanEck Biotech ETF Rating $162.00 +0.98 (+0.61%) As of 09:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.70Holdings in BBH have an aggregate rating of Moderate Buy based on 494 analyst ratings issued in the past year covering 24 companies (99.9% of the portfolio).BBH Aggregate Price Target$162.00High Prediction$162.00Average Prediction$162.00Low Prediction$162.00Holdings in BBH have an aggregate price target of $162.00 and a range of $162.00 to $162.00 covering 24 companies (99.9% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.35%AMGNAmgen$272.17-0.3%4.7753 of 5 stars2.30$309.70 13.8%20Positive NewsAnalyst Forecast12.67%GILDGilead Sciences$111.49-0.5%4.9234 of 5 stars2.89$117.17 5.1%28Positive News8.62%VRTXVertex Pharmaceuticals$387.06+0.3%4.8799 of 5 stars2.68$493.81 27.6%28Analyst Revision6.52%ALNYAlnylam Pharmaceuticals$449.56+0.7%3.5561 of 5 stars2.86$439.58 -2.2%286.11%ARGXargenex$718.62+1.0%4.1525 of 5 stars3.08$789.20 9.8%24Positive News5.64%INSMInsmed$138.69+1.2%3.0774 of 5 stars2.94$139.86 0.8%175.01%REGNRegeneron Pharmaceuticals$564.15+0.0%4.7657 of 5 stars2.82$817.67 44.9%28Positive News4.92%IQVIQVIA$178.18-0.8%4.9676 of 5 stars2.75$229.64 28.9%24Positive News4.22%NTRANatera$164.56+1.0%3.4893 of 5 stars3.00$192.88 17.2%19Positive News3.64%BIIBBiogen$136.20-0.9%4.6677 of 5 stars2.35$182.04 33.7%31Analyst Upgrade3.54%ICLRIcon$163.24-0.3%4.0416 of 5 stars2.68$216.67 32.7%193.35%ONCBeOne Medicines$327.80+0.5%1.7467 of 5 stars3.11$336.30 2.6%92.95%NBIXNeurocrine Biosciences$141.30-0.5%4.6256 of 5 stars2.85$161.89 14.6%202.75%ILMNIllumina$91.61-0.1%4.8327 of 5 stars2.21$123.06 34.3%19Positive News2.48%BNTXBioNTech$97.96-0.1%2.6636 of 5 stars2.79$134.56 37.4%142.32%INCYIncyte$84.12+1.7%4.692 of 5 stars2.33$83.67 -0.5%181.84%MRNAModerna$24.52+0.1%4.4452 of 5 stars2.05$41.81 70.5%221.62%TECHBio-Techne$51.90+0.1%4.9742 of 5 stars2.77$70.42 35.7%131.50%QGENQiagen$43.81-0.2%4.3132 of 5 stars2.27$49.69 13.4%111.50%CRLCharles River Laboratories International$146.12-1.6%4.5986 of 5 stars2.31$177.07 21.2%16Analyst Upgrade1.46%EXASExact Sciences$53.42-0.3%4.804 of 5 stars2.91$68.05 27.4%23Positive News1.38%BMRNBioMarin Pharmaceutical$54.01+0.3%4.933 of 5 stars2.64$92.60 71.5%22Positive News1.17%RGENRepligen$125.26-0.3%4.8453 of 5 stars2.75$168.75 34.7%12Positive NewsGap Up0.33%SRPTSarepta Therapeutics$18.40+0.2%4.4783 of 5 stars2.10$39.32 113.6%29 This page (NASDAQ:BBH) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
